- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
End of an Era as Cell Editor Steps Down
15 September 1999 7:30 pm
Benjamin Lewin, the editor of Cell and its sister journal Molecular Cell, announced to his staff and editorial board yesterday that he plans to retire on 1 October. His sudden departure represents "a big loss for Cell," says cell biologist Tony Hunter of the Salk Institute for Biological Studies in La Jolla, California. Reached by ScienceNOW, Lewin declined to comment, other than to deny rumors that he is ill.
After Lewin founded Cell in 1974, it quickly became a premier journal of molecular and cell biology. Scientists attribute the journal's success largely to Lewin's depth of scientific knowledge and hands-on management style. "It will be very different without Benjamin there," says Hunter, who has been on the journal's editorial board since 1980. "He was always there to talk with you about your paper or someone else's. This was in contrast with most other journals."
Lewin sold the journal, along with its three sister journals--Neuron, Immunity, and Molecular Cell--to Dutch science-publishing giant Elsevier Science in April, for an amount rumored to be close to $100 million. Insiders wondered how long Lewin would stay on, although Elsevier had announced he would remain editor for 5 years. Now, Deputy Editor Vivian Siegel will take over the helm, but some close to the journal suspect Lewin's departure, combined with Elsevier's takeover, will trigger an exodus of editorial staff.
"I don't think Cell can be Cell without Lewin," says molecular biologist Robert Tjian, also a member of the journal's editorial board. It is too early to tell whether individual editorial board members will stay on, he says.